Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – N-c doai
Reexamination Certificate
2006-02-14
2006-02-14
Price, Elvis O. (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
N-c doai
C514S278000, C514S415000, C514S440000, C514S603000, C514S640000, C564S265000, C564S300000, C564S459000
Reexamination Certificate
active
06998419
ABSTRACT:
Disclosed are 3,4,5-trisubstituted aryl nitrone compoundsd and pharmaceutical compositions containing such compounds. The 3,4,5-trisubstituted aryl nitrone compounds have formula (I); where R1–R4are as defined in the specification. The disclosed compositions are useful as therapeutics for inflammation-related conditions in mammals, such as arthritis, and as analytical reagents for detecting free radicals.
REFERENCES:
patent: 4224340 (1980-09-01), Campbell et al.
patent: 5025032 (1991-06-01), Carney et al.
patent: 5036097 (1991-07-01), Floyd et al.
patent: 5143928 (1992-09-01), Cetenko et al.
patent: 5145837 (1992-09-01), Feyen et al.
patent: 5215986 (1993-06-01), Connor et al.
patent: 5270319 (1993-12-01), Belliotti et al.
patent: 5405874 (1995-04-01), Carney et al.
patent: 5475032 (1995-12-01), Carney
patent: 5527828 (1996-06-01), Janzen et al.
patent: 5532277 (1996-07-01), Janzen et al.
patent: 5622994 (1997-04-01), Carney et al.
patent: 5681965 (1997-10-01), Carney et al.
patent: 5780510 (1998-07-01), Carney
patent: 5840746 (1998-11-01), Ducharme et al.
patent: 5942507 (1999-08-01), Kelleher et al.
patent: 5972977 (1999-10-01), Narducy et al.
patent: 5994396 (1999-11-01), Kelleher et al.
patent: 5998469 (1999-12-01), Kelleher et al.
patent: 6002001 (1999-12-01), Carney et al.
patent: 6015831 (2000-01-01), Kelleher et al.
patent: 6046232 (2000-04-01), Kelleher et al.
patent: 6083989 (2000-07-01), Flitter et al.
patent: 6140356 (2000-10-01), Narducy et al.
patent: 6258852 (2001-07-01), Flitter et al.
patent: 6342523 (2002-01-01), Waterbury
patent: 6730700 (2004-05-01), Waterbury et al.
patent: 0 371 438 (1990-06-01), None
patent: 0 945 426 (1999-09-01), None
patent: 2137619 (1984-10-01), None
patent: WO 91/05552 (1991-05-01), None
patent: WO 95/11227 (1995-04-01), None
patent: WO 97/39751 (1997-10-01), None
patent: WO 98/13332 (1998-04-01), None
patent: WO 99/20601 (1999-04-01), None
patent: WO 99/45909 (1999-09-01), None
patent: WO 99/59576 (1999-11-01), None
Corner et al., “Collagen-Induced Arthritis in Rats,”J. of Immunology, vol. 149, p. 1045-1053 (1992).
DeGray et al., “Biological Spin Trapping,”Electron Spin Resonance, vol. 14, pp. 2460399 (1994).
Evans, C.A., “Spin Trapping,”Aldrichimica Acta, Vol. 12, No. 2:23-29 (1979).
Evans A. T., et al., “Short Communications: Actions of Cannabis Constituents on Enzymes of Arachidonate Metabolism: Anti-inflammatory Potential,”Biochem Pharmacology, vol. 36, No. 12:2035-2037 (1987).
Lareson et al., “Homologous Type II Collagen-Induced Arthritis in Rats,”Arthritis&Rheumatism, vol. 33, pp. 693-701 (1990).
Maples et al., “In Vivo Detection of Free Radical Metabolites,”Free Radicals in Synthesis and Biology,pp. 423-436 (1989), Kluwer Academic Publishers, Boston, F. Minisci, ed.
Weichman et al., “Rate Adjuvant Arthritis: A Model of Chronic Inflammation,”Pharmacological Methods in the Control of Inflammation, pp. 363-380 (1989).
Winter et al., “Carrageenin-induced Edema in Hind Paw of the Rats as an Assay for Anti-Inflammatory Drugs,”Proc. Sci. Exp. Biol. Med., vol. 111, pp. 544-547 (1962).
Curran, William V.,et al. “The Synthesis of Deoxynegamycin and some Related Compounds,”J. of Antibioties, 21 (9), pp. 915-919 (1978).
Kondo, Shinichi et al., “Synthesis and Properties of Negamycin Analogs Modified the δ-Hydroxy-β-Lysine Moiety,”J. of Antibiotics, 29(2), pp. 209-221 (1976).
Kondo, Shinichi et al., “3-Epi-Deoxynegamycin and Leucyl-3-Epi-Deoxynegamycin Produced by Streptomyces,”J. of Antibiotics, 30(12), pp. 1137-1139 (1977).
Uehara, Yoshimasa et al., “Structure-Activity Relationships Among Negamycin Analogs,”J. of Antibiotics, 29(9), pp. 937-943 (1976).
Carney John M.
Danielzadeh Albert
Mavandadi Farah
Waterbury L. David
Wilcox Allan L.
Klauber & Jackson
Price Elvis O.
Renovis, Inc.
LandOfFree
3,4,5-trisubstituted aryl nitrone compounds and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3,4,5-trisubstituted aryl nitrone compounds and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,4,5-trisubstituted aryl nitrone compounds and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3684230